ENvue Medical, Inc. (FEED)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, ENvue Medical, Inc. reported revenue of $2.55M, down 0.2% from the prior year. The company ran a net loss, with a net margin of -712.3% and a gross margin of 6.0%. It held $41.12M in total assets against $7.63M in total liabilities.
Key ratios (FY2025)
6.0%
Gross margin
-896.6%
Operating margin
-712.3%
Net margin
-54.3%
Return on equity
-0.2%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.55M | $2.56M | $2.28M | $752.0K | $1.70M | $623.0K | $530.0K | $318.0K | — | — |
| Cost of Revenue | $2.40M | $1.05M | $746.0K | $585.0K | $925.0K | $409.0K | $249.0K | $158.0K | $88.0K | $88.0K |
| Gross Profit | $153.0K | $1.51M | $1.54M | $167.0K | $770.0K | $214.0K | $281.0K | $160.0K | $151.0K | $141.0K |
| Operating Income | -$22.89M | -$3.58M | -$3.44M | -$5.01M | -$5.68M | -$4.72M | -$5.15M | -$4.30M | -$3.09M | -$2.32M |
| Net Income | -$18.18M | -$3.71M | -$3.71M | -$5.45M | -$14.28M | -$4.33M | -$5.79M | -$4.15M | -$4.96M | -$2.83M |
| EPS (Diluted) | $-26.69 | $-137.30 | $-23.32 | $-3.84 | $-11.35 | — | — | — | — | — |
| Total Assets | $41.12M | $3.63M | $6.67M | $5.88M | $8.62M | $8.23M | $2.04M | $1.58M | $4.87M | $494.0K |
| Total Liabilities | $7.63M | $3.00M | $2.69M | $2.65M | $2.31M | $5.83M | $688.0K | $1.12M | — | — |
| Shareholders' Equity | $33.50M | $627.0K | $3.99M | $3.23M | $6.31M | $2.39M | $1.35M | $463.0K | $3.63M | -$2.50M |
| Cash & Equivalents | $4.22M | $752.0K | — | — | $7.74M | $7.14M | $1.34M | $896.0K | $4.36M | $106.0K |
| Operating Cash Flow | -$9.37M | -$2.52M | -$3.60M | -$7.04M | -$4.37M | -$3.39M | -$3.87M | -$3.55M | -$2.18M | -$1.53M |
| Capital Expenditures | $60.0K | $3.0K | $1.0K | $3.0K | $3.0K | $2.0K | — | $8.0K | — | $8.0K |
| Shares Outstanding | 1.10M | 37.9K | 186.0K | 1.64M | 1.40M | 21.25M | 4.20M | 3.80M | 3.94M | 2.63M |